Sotac Pharmaceuticals Limited IPO Review & Recommendations
Get Real-Time Updates on stock market trends and news
Get updates on stock market, Stock related news, Algo Trading, learn profitable strategies.
Join WhatsApp ChannelSotac Pharmaceuticals Limited IPO
March 29, 2023 - April 03, 2023
Closed
Apply with Angel One
Apply with Zerodha
Pre-Apply with Upstox
Sotac Pharmaceuticals Limited IPO Review
This Company was incorporated in 2015 and was engaged in manufacturing pharmaceutical products for different marketers on a loan license and contract manufacturing basis. Sotac is engaged in the business of pharma development & research. They have recently started a new SOTAC Lifescience Private Limited. Their competitive strengths are Scalable Business Model, Quality assurance, Experienced Promoters, and Management Team,
Their Business Strategy is Maintaining an edge over competitors, improving global presence, and Customer Satisfaction, Improve Product Portfolios, and Leveraging their market skills and relationship. Their Competition competes with organized players in the industry with financial position, product range, market share, human and other resources. Their business is majorly on a principle-to-principle basic with different marketers.
Sotac Pharmaceuticals Limited Products and Services
Their products and services are Beta-lactam drugs and SOTAC group manufacturing, specializing wide range of pharmaceutical products like Non-Beta-Lactam (general) tablets, and Non-Beta-Lactam (general) capsules. Their business models are research and development, Manufacturing of beta-lactam formulation through sotac healthcare, Manufacturing of nutraceutical medicine and food through, and Manufacturing of Nonbeta lactam formulation at their own plant.
Financial Overview
This Company is a healthcare, pharma company that is fluctuations in its the bottom lines for the reported periods. The issue is exorbitantly priced, and it operates in a highly competitive segment. There is no harm to skip this pricey IPO.
Frequently Asked Question
Sotac Pharmaceuticals Limited IPO shares will get listed on April 13, 2023.
Minimum and maximum order quantity is 1 lot only.
If you do not get the allotment of Sotac Pharmaceuticals Limited IPO shares, your IPO application amount will be released or credited back to your bank account via which you applied for this IPO.
Per share price of Sotac Pharmaceuticals Limited IPO is ₹105 to ₹111 per share.
IPO application is an online process by using UPI or ASBA as a payment method. ASBA IPO application is already available in the net banking of your respective bank account and the UPI application is offered by your Stockbroker, you can invest in SVS Limited IPO using any neatest method at your convenience.
Opening date of Sotac Pharmaceuticals Limited IPO is March 29, 2023.
If allotted, you will receive Sotac Pharmaceuticals Limited IPO shares in your Demat account on April 12, 2023.
Lot size of the Sotac Pharmaceuticals Limited IPO is 1200 shares.
Face value of Sotac Pharmaceuticals Limited IPO is ₹10 per share.
Pre-issue shareholding of the Sotac Pharmaceuticals Limited IPO promoter is 84.63%.
Sotac Pharmaceuticals Limited IPO Shares will get listed at NSE SME.
Closing date of Sotac Pharmaceuticals Limited IPO is April 03, 2023.
Comments for Sotac Pharmaceuticals Limited IPO Review & Recommendations
0 comments